JUBILANT INDUSTRIES share price has zoomed 5% and is presently trading at Rs 1,787.0.
Meanwhile, the BSE HEALTHCARE index is at 36,568.2 (down 0.5%).
Among the top gainers in the BSE HEALTHCARE index today are KIMS (up 1.5%) and Abbott India (up 0.9%).
MAX HEALTHCARE INSTITUTE (down 2.4%) and APOLLO HOSPITALS (down 1.6%) are among the top losers today.
Over the last one year, JUBILANT INDUSTRIES has moved up from Rs 527.7 to Rs 1,787.0, registering a gain of Rs 1,259.4 (up 238.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,266.1 to 36,568.2, registering a gain of 44.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 89.7%), Glenmark Pharma (up 86.4%) and GSK Pharma (up 85.9%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 78,074.0 .
The top gainers among the BSE Sensex today are Ultratech Cement (up 1.6%) and ICICI Bank (up 1.2%). The most traded stocks in the BSE Sensex are Tata Steel and ICICI Bank.
In the meantime, NSE Nifty is at 23,703.8 (down 0.1%). APOLLO HOSPITALS and Hindalco are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 62,970.0 to 78,074.0, registering a gain of 15,104.0 points (up 24.0%).
JUBILANT INDUSTRIES net profit grew 127.9% YoY to Rs 222 million for the quarter ended March 2024, compared to a profit of Rs 97 million a year ago. Net sales declined 12.5% to Rs 3,003 million during the period as against Rs 3,434 million in January-March 2023.
For the year ended March 2023, JUBILANT INDUSTRIES reported 3.3% decrease in net profit to Rs 528 million compared to net profit of Rs 546 million during FY22. Revenue of the company grew 26.3% to Rs 14,729 million during FY23.
The current Price to earnings ratio of JUBILANT INDUSTRIES, based on rolling 12 month earnings, stands at 92.2.
Equitymaster requests your view! Post a comment on "JUBILANT INDUSTRIES Gains 5%; BSE HEALTHCARE Index Down 0.5%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!